1 Patients
were excluded if 5-FU was used as adjuvant therapy, if t
2 Patients
were excluded if a definitive diagnosis of FEVR could no
3 Patients
were excluded if a diagnosis of FEVR could not be made.
4 Potential cases
were excluded if all pertinent donors tested negative.
5 Patients
were excluded if any surgery had been performed at an ou
6 Studies
were excluded if at least 1 study arm did not have ascor
7 Patients
were excluded if baseline K(+) was >5.0 mEq/L or serum c
8 Eyes
were excluded if central corneal thickness (CCT) or Ocul
9 Patients
were excluded if headache had lasted more than 3 days or
10 (> or =28 d) of each study were analyzed and
were excluded if individual intakes of calcium, copper,
11 Data
were excluded if individual intakes of magnesium, copper
12 Patients
were excluded if infarcts were located in both the anter
13 Children
were excluded if iron supplement use occurred within the
14 ing of article titles and abstracts, studies
were excluded if irrelevant to the topic of this systema
15 ast a 6-month follow-up period, and patients
were excluded if it was determined that intrathoracic re
16 Trials
were excluded if limited to participants older than 65 y
17 Studies
were excluded if mupirocin was not used for decolonizati
18 Residents
were excluded if one or more of the test scores were not
19 ients >12 h and up to 60 days after AMI, and
were excluded if patients were hemodynamically unstable.
20 Patients
were excluded if patients: (1) were screened by an outsi
21 Patients
were excluded if PH was secondary to left heart disease,
22 Articles
were excluded if reporting only intermediate outcomes (e
23 Patients
were excluded if temperature or route of temperature mea
24 HBeAg-negative chronic hepatitis would also
be excluded if testing were only performed at presentati
25 only performed at presentation and 30% would
be excluded if testing were performed on 3 occasions.
26 e dominant competitor over some of its range
being excluded if the area where it is dominant is too s
27 Studies
were excluded if the article was an unpublished disserta
28 Patients
were excluded if the attending surgeon had less than 24
29 Articles
were excluded if the cause of hepatitis was ambiguous or
30 Studies
were excluded if the duration was less than 6 months or
31 Mother-infant pairs
were excluded if the mothers intended to attend well-bab
32 Studies
were excluded if the population was selected according t
33 They
were excluded if the use of compression stockings was co
34 Patients
were excluded if their baseline serum creatinine was >1.
35 Patients
were excluded if their CABG surgery was combined with an
36 Patients
were excluded if their original consent forms to report
37 Patients
were excluded if their sequential visual fields showed a
38 Participants
were excluded if there was a comorbidity that could acco
39 Subjects
were excluded if there were medications or systemic or n
40 Studies
were excluded if they (1) failed to use VBM, (2) failed
41 Eyes
were excluded if they averaged fewer than 6.5 injections
42 Articles
were excluded if they dealt with pediatrics, geriatrics,
43 Patients
were excluded if they declined to participate, could not
44 Studies
were excluded if they described treatment of cervical gl
45 Responders
were excluded if they did not complete at least 1 health
46 Articles
were excluded if they did not contain a cohort with Alzh
47 Studies
were excluded if they did not evaluate colorectal screen
48 Articles
were excluded if they did not focus specifically on the
49 Patients
were excluded if they did not have a preoperative target
50 Participants
were excluded if they did not have longitudinal data, ap
51 of reproductive age were considered; studies
were excluded if they did not include individual-level p
52 For the primary key question, articles
were excluded if they did not provide a comparator as ke
53 Patients
were excluded if they did not receive a carbapenem after
54 tients (aged >/=60 years) with GBM; articles
were excluded if they did not report survival data from
55 to pre-DCR implementation and DCR groups and
were excluded if they died before completion of the init
56 Studies
were excluded if they enrolled pediatric patients, patie
57 Participants
were excluded if they exhibited performance outside the
58 Patients
were excluded if they had a family history of parental c
59 Subjects
were excluded if they had a history of a myocardial infa
60 Soldiers
were excluded if they had a medical or psychiatric condi
61 Subjects
were excluded if they had a previous diagnosis of chroni
62 Patients
were excluded if they had a previous revascularization.
63 Patients
were excluded if they had active brain metastases or act
64 Patients
were excluded if they had acute viral croup, tracheal su
65 Patients
were excluded if they had an open abdomen treatment in t
66 Patients
were excluded if they had any of these events before the
67 Women
were excluded if they had any signs of active cancer or
68 Subjects
were excluded if they had cardiac, pulmonary, liver, or
69 Patients
were excluded if they had comorbidities that associate w
70 Volunteers
were excluded if they had eczema, psoriasis, or other ch
71 Patients
were excluded if they had evidence of HCV genotype or su
72 Infants
were excluded if they had existing risk factors for neur
73 Potential subjects
were excluded if they had had previous glaucoma surgery
74 Patients
were excluded if they had HDV superinfection, liver infe
75 Patients
were excluded if they had hypotension, defined as either
76 Patients
were excluded if they had implantable cardioverter defib
77 Subjects
were excluded if they had moderate or high levels of ant
78 Patients
were excluded if they had not completed breast mound rec
79 Patients
were excluded if they had one or more of the following d
80 Potential participants
were excluded if they had previous experience with any o
81 Patients
were excluded if they had previously undergone B-KPro im
82 Patients
were excluded if they had received a previous kidney tra
83 Lesions
were excluded if they had solid enhancing components.
84 Patients
were excluded if they had stage 2 hypertension or known
85 Patients
were excluded if they had unreliable VFs (fixation losse
86 Studies
were excluded if they included only healthy volunteers,
87 Patients
were excluded if they opted out this service after the i
88 Patients
were excluded if they presented with a ST-elevation myoc
89 Studies
were excluded if they reported only intermediate physiol
90 Participants
were excluded if they reported using any form of tobacco
91 Lungs
were excluded if they showed any mismatched V/Q defect o
92 G1691A and prothrombin G20210A mutation and
were excluded if they tested positive.
93 Patients
were excluded if they underwent resection within 1 year
94 Patients
were excluded if they were coagulopathic, had no suitabl
95 Patients
were excluded if they were declared brain dead, were org
96 LS by revised El Escorial criteria; controls
were excluded if they were diagnosed as having ALS or an
97 From this set, IRs
were excluded if they were in unfinished/unassembled reg
98 Patients
were excluded if they were incontinent or impotent preop
99 Patients
were excluded if they were not English speakers, were no
100 Studies
were excluded if they were not RCTs, the antibiotics in
101 Trials
were excluded if they were phase 1, enrolled less than 1
102 addition to the inclusion criteria, patients
were excluded if they were pregnant, coinfected with HIV
103 Patients
were excluded if they were receiving a non-MEK inhibitor
104 Studies
were excluded if they were reporting: palliative care ex
105 Studies
were excluded if they were review articles, editorials,
106 Patients
were excluded if they were taking a higher statin dose i
107 Patients
were excluded if they were taking or expected to receive
108 Patients
were excluded if they were too well, too sick (in the se
109 Patients
were excluded if they were treated for medical disorders
110 Women
were excluded if they were vegetarians, consumed soy pro
111 Patients
were excluded if they were younger than 18 years, had a